|
Volumn 65, Issue 8, 2008, Pages 700-
|
Caution in prescribing antidepressants for patients with cancer
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMFEBUTAMONE;
AMITRIPTYLINE;
ANTIDEPRESSANT AGENT;
DESIPRAMINE;
DRUG METABOLITE;
ENDOXIFEN;
FLUOROURACIL;
FLUVOXAMINE;
NORTRIPTYLINE;
PAROXETINE;
PHENELZINE;
PLACEBO;
SEROTONIN UPTAKE INHIBITOR;
TAMOXIFEN;
TEGAFUR;
TRICYCLIC ANTIDEPRESSANT AGENT;
UNCLASSIFIED DRUG;
BREAST CANCER;
CANCER CHEMOTHERAPY;
CANCER PATIENT;
CANCER RISK;
DEPRESSION;
DISEASE ASSOCIATION;
DISEASE SEVERITY;
DRUG EFFICACY;
DRUG MEGADOSE;
DRUG METABOLISM;
DRUG SAFETY;
HUMAN;
LENGTH OF STAY;
LETTER;
LIVER CANCER;
PANCREAS CANCER;
PRESCRIPTION;
PRIORITY JOURNAL;
QUALITY OF LIFE;
TREATMENT DURATION;
|
EID: 42349095915
PISSN: 10792082
EISSN: None
Source Type: Journal
DOI: 10.2146/ajhp070656 Document Type: Letter |
Times cited : (4)
|
References (8)
|